JP2004514739A5 - - Google Patents

Download PDF

Info

Publication number
JP2004514739A5
JP2004514739A5 JP2002547487A JP2002547487A JP2004514739A5 JP 2004514739 A5 JP2004514739 A5 JP 2004514739A5 JP 2002547487 A JP2002547487 A JP 2002547487A JP 2002547487 A JP2002547487 A JP 2002547487A JP 2004514739 A5 JP2004514739 A5 JP 2004514739A5
Authority
JP
Japan
Prior art keywords
dispersion
aqueous
optionally
pharmaceutically acceptable
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002547487A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004514739A (ja
Filing date
Publication date
Priority claimed from GBGB0029562.6A external-priority patent/GB0029562D0/en
Application filed filed Critical
Publication of JP2004514739A publication Critical patent/JP2004514739A/ja
Publication of JP2004514739A5 publication Critical patent/JP2004514739A5/ja
Withdrawn legal-status Critical Current

Links

JP2002547487A 2000-12-04 2001-12-03 有機化合物 Withdrawn JP2004514739A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029562.6A GB0029562D0 (en) 2000-12-04 2000-12-04 Organic compounds
PCT/EP2001/014122 WO2002045703A2 (en) 2000-12-04 2001-12-03 Mixtures or organic compounds for the treatmentof airway diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007180977A Division JP2007302684A (ja) 2000-12-04 2007-07-10 有機化合物

Publications (2)

Publication Number Publication Date
JP2004514739A JP2004514739A (ja) 2004-05-20
JP2004514739A5 true JP2004514739A5 (https=) 2005-04-21

Family

ID=9904414

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002547487A Withdrawn JP2004514739A (ja) 2000-12-04 2001-12-03 有機化合物
JP2007180977A Pending JP2007302684A (ja) 2000-12-04 2007-07-10 有機化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007180977A Pending JP2007302684A (ja) 2000-12-04 2007-07-10 有機化合物

Country Status (27)

Country Link
US (5) US6800643B2 (https=)
EP (2) EP1772142A3 (https=)
JP (2) JP2004514739A (https=)
KR (1) KR100523541B1 (https=)
CN (1) CN1212119C (https=)
AT (1) ATE361077T1 (https=)
AU (2) AU1708202A (https=)
BR (1) BRPI0115910B8 (https=)
CA (1) CA2427282C (https=)
CY (1) CY1106727T1 (https=)
CZ (1) CZ304294B6 (https=)
DE (1) DE60128258T2 (https=)
DK (1) DK1341542T3 (https=)
EC (1) ECSP034620A (https=)
ES (1) ES2284732T3 (https=)
GB (1) GB0029562D0 (https=)
HU (1) HU229552B1 (https=)
IL (2) IL155709A0 (https=)
MX (1) MXPA03004976A (https=)
NO (1) NO325692B1 (https=)
NZ (1) NZ525731A (https=)
PL (1) PL204002B1 (https=)
PT (1) PT1341542E (https=)
RU (1) RU2292890C2 (https=)
SK (1) SK287331B6 (https=)
WO (1) WO2002045703A2 (https=)
ZA (1) ZA200303399B (https=)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US20040146509A1 (en) * 2002-07-25 2004-07-29 Zhihe Li Methods for improvement of lung function using TGF-beta inhibitors
PA8578101A1 (es) 2002-08-13 2004-05-07 Warner Lambert Co Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
US7250426B2 (en) * 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
TWI324151B (en) * 2003-04-02 2010-05-01 Novartis Ag Process for the preparation of 5-(haloacetyl)-8-substituted oxy-(1h)-quinolin-2-ones
GB0307856D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Organic compounds
BRPI0409198A (pt) * 2003-04-04 2006-05-02 Novartis Ag derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
KR100666220B1 (ko) * 2005-01-31 2007-01-09 영남대학교 산학협력단 구내염 치료용 분사제 조성물
EP2484382A1 (en) * 2005-03-30 2012-08-08 Schering Corporation Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
GB0511065D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
GB0511066D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
TW200744612A (en) * 2005-08-26 2007-12-16 Astrazeneca Ab New combination
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523655D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
BRPI0620225A2 (pt) * 2005-12-20 2011-11-01 Tika Läkemedel Ab métodos e sistemas para a distribuição de corticosteróides tendo um perfil farmacocinético aumentado
IN2015DN00888A (https=) 2006-02-22 2015-07-10 Mannkind Corp
US20070225233A1 (en) * 2006-03-27 2007-09-27 Tsu-Fuh Yeh Reducing the risk of chronic lung disease in infants
PT2044025E (pt) * 2006-06-30 2012-12-17 Novartis Ag Derivados de quinolinona e suas composições farmacêuticas
EP1878722A1 (en) * 2006-07-13 2008-01-16 Novartis AG Quinolinone derivatives and their pharmaceutical compositions
EP2534957B1 (en) 2007-12-14 2015-05-27 AeroDesigns, Inc Delivering aerosolizable products
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
PL3111927T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
KR100940388B1 (ko) * 2009-07-01 2010-02-02 유병덕 스크류탈수기 및 이를 포함하는 유기성폐기물 건조장치
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
CN103096897A (zh) * 2010-07-16 2013-05-08 希普拉有限公司 包含r(+)布地奈德和一种或多种支气管扩张剂的药物组合物
KR20180028563A (ko) * 2010-10-12 2018-03-16 시플라 리미티드 약학 조성물
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CN102247380A (zh) * 2011-08-19 2011-11-23 北京阜康仁生物制药科技有限公司 一种以布地奈德与茚达特罗为活性成分的复方制剂
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
WO2013132514A2 (en) * 2012-03-09 2013-09-12 Rao Davuluri Ramamohan A novel process for the preparation of (r)-5-[2-[(5, 6-diethyl-2, 3-dihydro-1h-inden-2-yl) amino]-1-hydroxyethyl]-8-hydroxy quinolin-2(1h)-one
WO2014008639A1 (zh) * 2012-07-11 2014-01-16 上海威智医药科技有限公司 制备茚达特罗的方法
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
WO2014044288A1 (en) * 2012-09-21 2014-03-27 Crystal Pharma Sa Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
ITUB20153978A1 (it) * 2015-09-28 2017-03-28 Laboratorio Chimico Int S P A Procedimento per la preparazione di derivati di indanammina e di nuovi intermedi di sintesi.
CN107868045A (zh) * 2016-09-28 2018-04-03 四川海思科制药有限公司 一种茚达特罗中间体的制备方法
CN106831445B (zh) * 2016-11-22 2019-01-22 斯芬克司药物研发（天津）股份有限公司 一种茚基胺化合物的制备方法
CN110229078A (zh) * 2019-05-22 2019-09-13 博诺康源(北京)药业科技有限公司 一种茚达特罗起始原料开环杂质的制备
CN114751857A (zh) * 2022-04-29 2022-07-15 梯尔希（南京）药物研发有限公司 一种茚达特罗杂质的制备方法
KR102748506B1 (ko) 2024-07-02 2024-12-31 주식회사 지티피에스 자동 청소기능을 갖는 건조장치

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
WO1993018007A1 (fr) * 1992-03-13 1993-09-16 Tokyo Tanabe Company Limited Nouveau derive de carbostyrile
MY107767A (en) * 1992-04-10 1996-06-15 Merck Frosst Canada Inc Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
GB9405019D0 (en) 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
GB9501286D0 (en) * 1995-01-24 1995-03-15 Ciba Geigy Ag Pharmaceutical compositions and preparations thereof
DE69630639T2 (de) * 1995-08-16 2004-09-16 Huntington Medical Research Institutes, Pasadena Rhodamin 123 Zusammensetzungen für Behandlung von Prostatakrebs
GB9603237D0 (en) 1996-02-16 1996-04-17 Sandoz Ltd Organic compounds
TW375604B (en) 1996-02-19 1999-12-01 Kissei Pharmaceutical 3,4-di-substituting phenyl-ethanolamine-tetrahydronaphthyl carboxylic amide derivatives
GB9610122D0 (en) * 1996-05-15 1996-07-24 Reckitt & Colmann Prod Ltd Organic compositions
ES2149742T1 (es) * 1997-07-03 2000-11-16 Asahi Chemical Ind Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos.
RU2202340C2 (ru) * 1998-05-27 2003-04-20 Юроселтик С.А. Система доставки лекарства
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US6448239B1 (en) 1999-06-03 2002-09-10 Trustees Of Princeton University Peroxynitrite decomposition catalysts and methods of use thereof
US6664235B1 (en) * 1999-08-20 2003-12-16 Riken Medicaments comprising sialic acid derivatives as active ingredients
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2004514739A5 (https=)
CA2427282A1 (en) Mixtures or organic compounds for the treatment of airway diseases
WO2012047674A2 (en) Methods and compositions for disease treatment using inhalation
PT1480615E (pt) Formulação superfina de formoterol
JP2004500429A (ja) チオトロピウム及びロフレポニドを含む医薬用の組み合わせ
JP2002538110A5 (https=)
IT9048260A1 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
JP2011528355A (ja) 充血除去剤およびコルチコステロイドを含む鼻腔内粗製物
JP2010539182A (ja) 治療剤の新規組み合わせ
RU2014140674A (ru) Новая дозировка и препаративная форма
JP2015519356A5 (https=)
JP2007522141A5 (https=)
CN103582477A (zh) 包含芜地溴铵和皮质类固醇的组合
SE527190C2 (sv) Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
CA2948553A1 (en) Combinations of tiotropium bromide, formoterol and budesonide for the treatment of copd
WO2000053187A1 (en) New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
JP3691459B2 (ja) 粉末状吸入剤組成物
JP5501451B2 (ja) 咳の治療のためのテオブロミン
JP2004500434A (ja) サルメテロールとブデソニドを含む組合せ医薬
EA007375B1 (ru) Композиции для ингаляции с высоким содержанием лекарственных веществ
HRP20140818T1 (hr) Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata
CA2701956A1 (en) Combination therapy
JP2004500432A (ja) モメタゾンとサルメテロールを含む組合せ医薬
JP2011500731A5 (https=)
PT1711164E (pt) Método de tratamento da rinossinusite aguda